Clinical Trials Directory

Trials / Completed

CompletedNCT02724644

EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
375 (actual)
Sponsor
Endo Pharmaceuticals · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The study will evaluate the safety, effectiveness, and immunogenicity of EN3835 in the treatment of adult women with Edematous Fibrosclerotic Panniculopathy (Commonly known as Cellulite).

Conditions

Interventions

TypeNameDescription
BIOLOGICALCOLLAGENASE CLOSTRIDIUM HISTOLYTICUMInjectable intervention
BIOLOGICALPlacebo Comparator

Timeline

Start date
2016-02-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-03-31
Last updated
2017-11-06
Results posted
2017-11-06

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02724644. Inclusion in this directory is not an endorsement.